# Pembrolizumab (Genetical Recombination) I.V. Infusion 100mg (キイトルーダ点滴静注１００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291435A2025). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291435A2025
- **Product name (Japanese):** キイトルーダ点滴静注１００ｍｇ
- **English title:** Pembrolizumab (Genetical Recombination) I.V. Infusion 100mg
- **Active ingredient:** ペムブロリズマブ（遺伝子組換え）
- **Active ingredient (INN):** Pembrolizumab (Genetical Recombination)
- **Strength / unit:** １００ｍｇ４ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** MSD (ＭＳＤ)
- **NHI price (reference only):** JPY 199462 per １００ｍｇ４ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291435A2025
- **JSON:** https://www.nifujipharma.com/api/drugs/4291435A2025

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Pembrolizumab%20(Genetical%20Recombination)%20I.V.%20Infusion%20100mg%20(%E3%82%AD%E3%82%A4%E3%83%88%E3%83%AB%E3%83%BC%E3%83%80%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%91%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291435A2025#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.